Tessa Eagle

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND The recent approval of oral disease-modifying therapies (DMTs) for multiple sclerosis (MS) has provided patients with a new route of therapy administration. Little research has compared patients' experiences with and perceptions of injectable, infusion and oral MS therapies. METHODS Three hundred fifty-seven treated MS patients enrolled in the(More)
SETTING Physician offices and hospital-based settings in 24 European Union countries. OBJECTIVES To assess the awareness of tuberculosis (TB) risk, performance of TB screening and factors predicting TB screening among prescribers of tumor necrosis factor alpha (TNF-α) agents. METHODS A total of 915 prescribers (441 rheumatologists, 266(More)
  • 1